HGF and melanoma: In this genetically engineered melanoma model, transgenic, metallothionein promoter-driven overexpression of the hepatocyte growth factor (Hgf) that deregulates receptor tyrosine kinase signaling is combined with an oncogenic CDK4R24C germline mutation that impairs cell cycle control.